Dendreon Announces Senior Management Change
Dendreon Corporation announced Martin A. Simonetti will step down as senior vice president of finance, chief financial officer and treasurer to spend more time with his family and to eventually pursue opportunities to lead a biotechnology company. This change will be effective in the third quarter of this year.
"We are grateful for Marty's contributions to the growth and development of our business during his more than six years at Dendreon, particularly with respect to successful fund raising and sound financial management," said Mitchell H. Gold, M.D., Dendreon's president and chief executive officer. "Marty has worked diligently to meet the many new requirements of corporate governance, including those of the Sarbanes-Oxley Act. I want to thank Marty for his contributions and wish him the very best for the future."
"I am pleased to have been a member of the executive management team at Dendreon and to have been intimately involved in the growth of the business," said Mr. Simonetti. "The finance organization is solid and will be a key part of the foundation for the next phase of Dendreon's growth. I am looking forward to spending some time with my family and to the next phase of my career."
The Company has initiated a search for the position.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
